A Fulminant Hepatitis Case Triggered by COVID-19 Disease

Year 2021, Volume: 4 Issue: 2, 50 - 54, 31.10.2021

Deniz İncaman

Abstract

The COVID-19 pandemic, known as acute respiratory syndrome coronavirus 2 (SARS-CoV-2), corona disease 2019 (COVID-19), was seen for the first time in December 2019 in Wuhan, China, has affected billions of people all over the world. It has been seen that gastrointestinal system involvement and fecal-oral spread are also significant as researches on the virus are performed, however, it was initially seen as a respiratory tract infection. We will talk about a case of hepatitis with a fulminant course due to COVID-19 in our article.

Keywords

COVID-19, ethylism, hepatitis

COVID-19 Hastalığının Tetiklediği Fulminan Hepatit Vakası

Abstract

COVID-19 pandemisi Çin’in Wuhan kentinde, Aralık 2019’da ilk defa görülen akut respiratory syndrome coronavirus 2 (SARS- CoV-2), corona hastalığı 2019 (COVID-19) olarak bilinen, tüm dünyada milyarlarca insanı etkilemiştir. Başlarda yalnızca solunum yolu enfeksiyonu gibi görülse de, virüsle ilgili araştırmalar yapıldıkça gastrointestinal sistem tutulumu ve fekal oral yayılımın da önemli olduğu görülmüştür. Biz makalemizde; COVID-19’a bağlı fulminan seyreden bir hepatit vakasından bahsedeceğiz.

Keywords

COVID-19, etilizm, hepatit

References

• Referans1 Chai X, Hu L, Zhang Y, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019‐nCoV infection. bioRxiv. 2020. 10.1101/2020.02.03.931766.
• Referans2 Bertolini A, van de Peppel IP, Bodewes FAJA, et al. Abnormal liver function tests in COVID-19 patients: relevance and potential pathogenesis. Hepatology 2020. Version of Record. doi: 10.1002/hep.31480